Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

SHE:002653 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 27, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	57,371	36,883	25,545	23,695	21,747	18,638
Market Cap Growth	64.12%	44.38%	7.81%	8.96%	16.68%	-14.41%
Enterprise Value	58,225	37,658	26,256	25,227	22,521	19,066
Last Close Price	51.72	33.00	22.72	21.84	19.79	16.76
PE Ratio	190.31	93.27	86.56	85.52	63.02	29.28
Forward PE	109.27	58.20	60.57	69.53	62.77	23.76
PS Ratio	13.44	9.91	7.61	7.86	7.84	5.60
PB Ratio	13.58	8.78	6.13	7.56	7.45	6.53
P/TBV Ratio	21.49	12.56	7.45	10.18	10.07	8.10
P/FCF Ratio	252.43	26513.20	436.15	-	-	-
P/OCF Ratio	90.31	83.44	56.82	250.62	607.43	90.39
EV/Sales Ratio	13.64	10.12	7.83	8.37	8.12	5.73
EV/EBITDA Ratio	118.38	75.57	48.24	79.50	122.44	57.27
EV/EBIT Ratio	254.75	143.72	79.19	178.20	598.98	83.50
EV/FCF Ratio	256.19	27070.49	448.29	-	-	-
Debt / Equity Ratio	0.57	0.46	0.43	0.67	0.43	0.38
Debt / EBITDA Ratio	5.54	3.76	3.28	6.48	6.55	3.23
Debt / FCF Ratio	11.02	1373.28	30.84	-	-	-
Asset Turnover	0.60	0.55	0.53	0.55	0.56	0.66
Inventory Turnover	3.95	3.84	3.10	3.05	3.91	5.17
Quick Ratio	1.64	1.48	1.50	1.09	0.81	1.04
Current Ratio	1.89	1.74	1.76	1.38	1.02	1.22
Return on Equity (ROE)	10.55%	11.14%	8.09%	12.94%	17.93%	22.98%
Return on Assets (ROA)	1.54%	2.44%	3.26%	1.60%	0.47%	2.84%
Return on Capital (ROIC)	1.69%	2.71%	3.69%	1.88%	0.58%	3.86%
Return on Capital Employed (ROCE)	3.00%	5.00%	6.40%	3.10%	1.10%	7.00%
Earnings Yield	0.54%	1.07%	1.16%	1.17%	1.59%	3.42%
FCF Yield	0.40%	0.00%	0.23%	-2.56%	-3.07%	-2.12%
Dividend Yield	0.80%	1.26%	0.88%	-	0.94%	2.22%
Payout Ratio	108.65%	106.72%	14.43%	89.32%	123.52%	20.54%
Buyback Yield / Dilution	-2.60%	-3.37%	-2.57%	1.17%	0.07%	-0.50%
Total Shareholder Return	-1.80%	-2.11%	-1.69%	1.17%	1.00%	1.72%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.